Cabot (NYSE:CBT) was upgraded by stock analysts at SunTrust Banks from a “hold” rating to a “buy” rating in a report issued on Tuesday. SunTrust Banks also issued estimates for Cabot’s Q2 2018 earnings at $1.00 EPS, Q3 2018 earnings at $1.06 EPS, Q4 2018 earnings at $1.08 EPS, FY2018 earnings at $3.87 EPS and FY2019 earnings at $4.27 EPS.

A number of other equities research analysts have also recently issued reports on CBT. Loop Capital began coverage on shares of Cabot in a report on Thursday, September 28th. They issued a “hold” rating and a $59.00 target price on the stock. Jefferies Group reaffirmed a “buy” rating and issued a $74.00 target price on shares of Cabot in a report on Friday, November 3rd. KeyCorp reaffirmed a “hold” rating on shares of Cabot in a report on Wednesday, November 1st. Finally, Zacks Investment Research cut shares of Cabot from a “buy” rating to a “hold” rating in a report on Tuesday, November 7th. Six research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $61.14.

Shares of Cabot (NYSE CBT) opened at $61.82 on Tuesday. The company has a quick ratio of 1.17, a current ratio of 1.70 and a debt-to-equity ratio of 0.41. The stock has a market cap of $3,615.38, a PE ratio of 17.01, a PEG ratio of 1.55 and a beta of 1.11. Cabot has a fifty-two week low of $50.21 and a fifty-two week high of $64.66.

Cabot (NYSE:CBT) last issued its earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.91 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.93 by ($0.02). The firm had revenue of $723.00 million during the quarter, compared to the consensus estimate of $683.30 million. Cabot had a net margin of 8.87% and a return on equity of 15.11%. The firm’s revenue for the quarter was up 16.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.00 earnings per share. analysts predict that Cabot will post 3.77 earnings per share for the current year.

A number of institutional investors have recently added to or reduced their stakes in CBT. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Cabot by 9.2% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,469 shares of the specialty chemicals company’s stock valued at $132,000 after acquiring an additional 209 shares during the period. Old Mutual Global Investors UK Ltd. bought a new position in Cabot in the 2nd quarter valued at about $155,000. Parametrica Management Ltd bought a new position in Cabot in the 3rd quarter valued at about $217,000. Virginia Retirement Systems ET AL bought a new position in Cabot in the 3rd quarter valued at about $218,000. Finally, Quantbot Technologies LP raised its holdings in Cabot by 244.4% in the 2nd quarter. Quantbot Technologies LP now owns 4,643 shares of the specialty chemicals company’s stock valued at $248,000 after acquiring an additional 3,295 shares during the period. 84.83% of the stock is currently owned by hedge funds and other institutional investors.

WARNING: “Cabot (CBT) Rating Increased to Buy at SunTrust Banks” was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/12/21/cabot-cbt-rating-increased-to-buy-at-suntrust-banks.html.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.